• Subscribe
    e

    Xconomy’s Digital Events →

    ▾
  • Xconomy National

  • Our
    Regions
    • National ›
      • Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
        Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
      View More in National ›
    • Europe ›
      • FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
        FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
      View More in Europe ›
    • Boston ›
      • Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
        Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
      View More in Boston ›
    • Boulder/Denver ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Boulder/Denver ›
    • Detroit/Ann Arbor ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Detroit/Ann Arbor ›
    • Indiana ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Indiana ›
    • New York ›
      • “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
        “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
      View More in New York ›
    • Philadelphia ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Philadelphia ›
    • Raleigh-Durham ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Raleigh-Durham ›
    • San Diego ›
      • Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
        Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
      View More in San Diego ›
    • San Francisco ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in San Francisco ›
    • Seattle ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Seattle ›
    • Texas ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Texas ›
    • Wisconsin ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Wisconsin ›
  • Topic
    Channels
    • Life Sciences›
        View More in Life Sciences ›
      • Healthtech›
          View More in Healthtech ›
        • Robotics and A.I.›
            View More in Robotics and A.I. ›
          • Startups›
              View More in Startups ›
          • Our
            Events
            • All Xconomy Events ›
          • Xconomy
            Insight

          “keros-therapeutics” Archives

          in
          Entry Author Date Location
          Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses Frank Vinluan 05/01/20 Boston
          Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More Frank Vinluan 04/10/20 National
          Keros Therapeutics Raises $96M in Upsized IPO to Fuel Clinical Tests Sarah de Crescenzo 04/08/20 Boston
          Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More Frank Vinluan 03/27/20 National
          Investors Shaken by Coronavirus Sow Seeds of M&A, Financing Slowdown Sarah de Crescenzo 03/23/20 National
          Keros Outlines IPO Plans Amid Markets Rocked by Coronavirus Pandemic Sarah de Crescenzo 03/23/20 Boston
          Bio-JPM Roundup: Lilly Buys Loxo, Sage’s Stock Soars, ALS Cash & More Frank Vinluan 01/07/19 National
          Page 1 of 1

          Underwriters and Partners

          Xconomy Insight
          • Decentralized Clinical Trials: The Call for a New Paradigm

            Sponsored · Whitepaper

            Decentralized Clinical Trials: The Call for a New Paradigm

            Virtual/hybrid trials and decentralized research can better integrate healthcare into patients’ lives and accelerate approval of new medications

            PRA Health Sciences
          • As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

            Sponsored · Special Report

            As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

            Hyperinflation in rents is over

            Hughes Marino
          • How Healthy Are Your Market Access Programs?

            Sponsored · Whitepaper

            How Healthy Are Your Market Access Programs?

            A Guide to Performing Check-ups on Pharmaceutical Distribution & Patient Access Programs

            Archbow Consulting

          Xconomy on Demand

          We offer a number of ways to subscribe for free!

          Subscribe Now
          Informa Connect Logo Informa Connect Logo
          • Home
          • Privacy Policy
          • Security Disclosures
          • About
          • Contact Us
          • Archives
          • Advertise
          • Subscribe for Free

          © 2007-2022, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.